Intimal deposition of functional von Willebrand factor in atherogenesis.

During the formation of intimal thickening in normocholesterolemic rabbits, von Willebrand factor (vWF) is increased in the endothelial cells (ECs) and deposited in the intima. We investigated whether this also occurs during cholesterol-induced plaque formation, whether the synthesis of vWF increases, and whether this influences platelet adhesion. Rabbits were fed a cholesterol-rich (0.3%) diet for 26 weeks. Thereafter, half of the animals received a normal diet for another 26 weeks (cholesterol withdrawal). To induce intimal thickening in normocholesterolemic rabbits, collars were positioned around the carotid artery. Arterial segments were studied using immunohistochemistry, reverse transcription-polymerase chain reaction, electron microscopy, and platelet adhesion tests. Cholesterol treatment induced plaque formation in the aorta. The ECs had a cuboidal aspect, showed a dense immunoreactivity for vWF, a pronounced rough endoplasmic reticulum, and numerous Weibel-Palade bodies. There were subendothelial vWF deposits in the plaques and vWF mRNA was significantly increased as compared with controls. Similar changes were seen after collar-induced intimal thickening. After cholesterol withdrawal, both vWF mRNA and the ultrastructural morphology of the ECs normalized, and the vWF deposits disappeared from the plaque. Perfusion studies with anticoagulated rabbit blood over cross-sections of atherosclerotic aortas revealed increased vWF-mediated platelet adhesion in the subendothelial plaque region. Whereas rabbit platelets perfused through the lumen adhered to the same extent to de-endothelialized aortas of normocholesterolemic and atherosclerotic rabbits, vWF mediated platelet adhesion to endothelium was observed in atherosclerotic but not in normal aortas. Our results show an increased synthesis and (sub)endothelial presence of vWF after vascular injury, with functional consequences for platelet deposition on the vessel wall.

[1]  P. Mannucci,et al.  von Willebrand factor: a marker of endothelial damage? , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[2]  G. D. De Meyer,et al.  Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. , 1998, Circulation research.

[3]  E. Vicaut,et al.  Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. , 1998, Circulation.

[4]  K. Kugiyama,et al.  Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Bellinger,et al.  von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[6]  M. Lewis,et al.  Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. V. Van Schil,et al.  Possible mechanisms of collar-induced intimal thickening. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Remuzzi,et al.  Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. , 1997, Blood.

[9]  A. Blann,et al.  von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. , 1997, Atherosclerosis.

[10]  G. Lip,et al.  von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? , 1997, Cardiovascular research.

[11]  M. Condorelli,et al.  Inhibition of Leucocyte and Platelet Adhesion Reduces Neointimal Hyperplasia after Arterial Injury , 1997, Thrombosis and Haemostasis.

[12]  C. Vrints,et al.  Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Lin,et al.  Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. , 1996, Atherosclerosis.

[14]  E. Lesaffre,et al.  Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure , 1996, Thrombosis and Haemostasis.

[15]  S. Santavirta,et al.  Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. , 1996, The Journal of rheumatology.

[16]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[17]  C. Ferran,et al.  Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation , 1995 .

[18]  J. Sixma,et al.  Increased platelet deposition on atherosclerotic coronary arteries. , 1994, The Journal of clinical investigation.

[19]  G. D. De Meyer,et al.  The endothelium during cuff-induced neointima formation in the rabbit carotid artery. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  A. Federici,et al.  Autopsy Findings in Three Patients with von Willebrand Disease Type IIB and Type III: Presence of Atherosclerotic Lesions without Occlusive Arterial Thrombi , 1993, Thrombosis and Haemostasis.

[21]  V. Fuster,et al.  von Willebrand Factor and Cardiovascular Disease , 1993, Thrombosis and Haemostasis.

[22]  J. V. van Mourik,et al.  Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types , 1992, British journal of haematology.

[23]  D. Warshaw,et al.  Nucleotide sequences of the rabbit α-smooth-muscle and β-non-muscle actin mRNAs ☆ , 1992 .

[24]  K. Bürrig,et al.  The endothelium of advanced arteriosclerotic plaques in humans. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  D. Bellinger,et al.  Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs. , 1991, Circulation.

[26]  R. M. Lee,et al.  Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1990, Atherosclerosis.

[27]  D. Tate,et al.  von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. , 1990, Arteriosclerosis.

[28]  P. Isaacson Ultrastructural Pathology of the Cell and Matrix: a Text and Atlas of Physiological and Pathological Alterations in the Fine Structure of Cellular and Extracellular Components , 1989 .

[29]  S. Schwartz,et al.  Injury induces increase of von Willebrand factor in rat endothelial cells. , 1989, The American journal of pathology.

[30]  F. N. Ghadially Ultrastructural pathology of the cell and matrix , 1988 .

[31]  J. Sixma,et al.  Interleukin‐l Inhibits the Synthesis of von Willebrand Factor in Endothelial Cells, Which Results in a Decreased Reactivity of Their Matrix toward Platelets , 1987, Arteriosclerosis.

[32]  A. Schorer,et al.  Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells , 1987, British journal of haematology.

[33]  J. Giddings,et al.  Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. , 1987, Thrombosis research.

[34]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[35]  D. Wagner,et al.  Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.

[36]  L. Badimón,et al.  The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells. , 1984, Atherosclerosis.

[37]  P. D. de Groot,et al.  The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. , 1983, Biochimica et biophysica acta.

[38]  J. Rand,et al.  Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. , 1982, The Journal of laboratory and clinical medicine.

[39]  V. Fuster,et al.  Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. , 1978, The Journal of clinical investigation.

[40]  J. Vermylen,et al.  Antagonism of vWF Inhibits both Injury Induced Arterial and Venous Thrombosis in the Hamster , 1998, Thrombosis and Haemostasis.

[41]  C. Ferran,et al.  Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. , 1995, Biochemical and biophysical research communications.

[42]  P. Libby,et al.  Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque , 1995, Journal of cardiovascular pharmacology.

[43]  D. Wagner Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.

[44]  S. Breit,et al.  Modulation of endothelial cell synthesis of von Willebrand factor by mononuclear cell products. , 1988, Haemostasis.

[45]  F. N. Ghadially Rod-shaped microtubulated bodies , 1988 .